"Church & Dwight has risen 6% this year, less than major U.S. indices. The stock trades at a price-to-earnings ratio of 18, which is on par with household-product makers, but a discount to the market. The shares offer a 1% dividend yield."

Kaminsky mentioned three companies that may get together or be acquired. They were Clorox(CLX), Church and Dwight(CHD) and Ecolab(ECL). He said all three benefit from the trends toward cleanliness and health care. Out of that list, I like CHD, adds Guy Adami.

Church & Dwight is up 5% in 2009, underperforming major U.S. indices. The stock trades at an expensive price-to-earnings ratio of 19 and offers a dividend yield below 1%. The company's record of consistent earnings growth regardless of economic conditions makes it an attractive investment.

raised its regular quarterly dividend to 14 cents from 9 cents. The company will pay the dividend on Sept. 1 to shareholders of record Aug. 13

"This is another one that's too defensive for this market. In a recession, it does well, but not anymore." ("Mad Money Lightning Round," 4-9-09)

Fans of diversification and hedging will appreciate how Church & Dwight (CHD) sells both Trojan condoms and First Response home-pregnancy test kits -- along with Arm & Hammer cleaning products, Brillo pads and other cheap necessities that belt-tightening consumers can't easily relinquish. But that defensive portfolio and modest debt load have lifted shares to 18 times 2009 earnings, above the 14.5 times for household products, making it tough to argue that Church & Dwight is an undiscovered Procter & Gamble.

Other names Adami thinks have been unfairly punished during this sell-off include Johnson & Johnson [JNJ] Church & Dwight [CHD] and Celgene [CELG].

Church & Dwight (CHD) upgraded at UBS. Rating raised to buy from neutral. Maintains 2008 EPS estimates of $2.85 and $64 price target.

Johnson & Johnson [JNJ] or Church and Dwight [CHD], adds Guy Adami.

That Lightning Round caller in May was sooo right about this one.

too expensive